Estrella Immunopharma, Inc. ESLA Q4 2025 Annual earnings
Reported March 18, 2026 · Before market open
EPS-$0.02Beat by $0.16
EPS estimate-$0.18
Next report
Sep 2, 2026 (in a month)EPS estimate-$0.09
Versus estimates
Diluted EPS
Ask the moment Estrella Immunopharma, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Estrella Immunopharma, Inc. report Q4 2025 earnings?
- Estrella Immunopharma, Inc. (ESLA) reported Q4 2025 earnings on March 18, 2026 before market open.
- What were Estrella Immunopharma, Inc.'s Q4 2025 revenue and EPS?
- Estrella Immunopharma, Inc. reported eps of $-0.02 for Q4 2025.
- Did Estrella Immunopharma, Inc. beat estimates in Q4 2025?
- EPS beat the consensus estimate of $-0.18 by $0.16.
- How did Estrella Immunopharma, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 43.4% from $-0.03.
- Where can I find Estrella Immunopharma, Inc.'s Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001213900-26-029357) directly on SEC EDGAR. The filing index links above go to sec.gov.